Surgacoll to raise €3m for new product

SurgaColl is a spin-out of the Royal College of Surgeons in Ireland

Fergal O’Brien, professor of bioengineering and regenerative medicine and head of tissue engineering research group, RCSI; John O’Dea, manager, high-potential start-ups – industrial, Enterprise Ireland; Eric Reed, non-executive director, and John Gleeson, chief executive, both of SurgaColl Technologies

Company:Surgacoll

Done deal:€3m investment round

The clincher:“This is a product with great potential for early intervention in joint injuries, minimising long-term damage and potentially reducing the risk of osteoarthritis and need for knee-replacement surgery” - John O Byrne, Department of Orthopaedic Surgery, RCSI

SurgaColl, a spin-out of the Royal College of Surgeons in Ireland, will raise up to €3 million in investment within three months as it begins to market bone regeneration technology, ...